Notice Number: NOT-DA-08-013

Key Dates
Release Date: April 23, 2008

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

This Notice announces the participation of the National Institute on Drug Abuse (NIDA) in PA-08-107, PA-08-108, and PA-08-109, Prevention Research with HIV Positive Individuals.

The following Institutes continue to participate in PA-08-107, PA-08-108, and PA-08-109. All other aspects of these FOAs remain unchanged.

The National Institute of Mental Health (NIMH) (http://www.nimh.nih.gov/)
National Institute of Nursing Research (NINR), (http://www.ninr.nih.gov/)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), (http://www.nichd.nih.gov/)

NIDA will support applications that address secondary prevention among HIV seropositive drug using populations, including injection and non-injection drug users, as well as providers and settings that offer health care, drug treatment or public health services to HIV seropositive drug using populations. NIDA encourages applications regarding secondary prevention interventions, as well as descriptive research which can inform secondary prevention intervention.

Inquiries

Scientific/research questions about this Notice should be directed to:

Richard A. Jenkins, Ph.D.
Health Scientist Administrator
Prevention Research Branch
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd., Rm. 5185 MSC 9589
Bethesda, MD 20892-9589
Telephone: (301) 443-1923
Fax: (301) 480-2542
E-mail: [email protected]

Grants Managaement questions \should be directed to:

Maryellen Connell
Grants Management Specialist
Grants Management Branch
National Institute on Drug Abuse
6101 Executive Boulevard
Suite 270 MSC 8403
Bethesda MD  20892-8403
Telephone: (301) 443-6710
FAX : (301) 594-6847
E-mail: [email protected]